Search Results 151-160 of 16730 for alt

  1. Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma - Mayo Clinic

    ANC ≥ 1500/mcL, AST and ALT < 2 x upper limit of normal (ULN), total bilirubin ≤ 3 mg/dL, creatinine clearance ≥ 50 mL/min, platelet count ≥ 100,000/mcL ...

  2. A Study to Test the Addition of Nivolumab to Chemotherapy to Treat Soft Tissue Sarcoma - Mayo Clinic

    Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ≤ 2.5 x upper limit of normal (ULN). For patients with significant hepatic metastases, ALT and ...

  3. A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma - Mayo Clinic

    If attributed to tumor involvement, AST and ALT <5×ULN. Subjects a history of hepatitis (Exclusion Criterion No. 11) must have ALT within the normal range.

  4. A Study to Compare ACP-196 and Obinutuzumab with Chlorambucil, or ACP-19 alone, with Obinutuzumab and Chlorambucil, for Patients with Previously Untreated Chronic Lymphocytic Leukemia - Mayo Clinic

    Serum AST and ALT/SGPT ≤ 3.0 x ULN; Total bilirubin ≤ 1.5 x ULN; Estimated creatinine clearance ≥ 30 mL/min. Exclusion Criteria. Any prior systemic treatment ...

  5. Iobenguane I-131 Or Crizotinib And Standard Therapy In Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma Or Ganglioneuroblastoma - Mayo Clinic

    ... [ALT]) < 10 x ULN; for the purposes of this study, ULN for SGPT (ALT) is 45 - Shortening fraction of >= 27% by echocardiogram, or ejection fraction of ...

  6. A Study to Investigate the Effectiveness and Safety of Cannabidiol (GWP42003-P; CBD) as an Added Treatment for the Seizures Associated with Lennox-Gastaut Syndrome in Children and Adults - Mayo Clinic

    Alanine aminotransferase [ALT] >5 x upper limit of normal [ULN]; Or total bilirubin [TBL] >2 x ULN; Or the ALT or Aspartate aminotransferase (AST) >3 x ULN ...

  7. A Study of Donated Alloantigen Reactive Regulatory T Cells for Reducing or Discontinuing Immune System Suppression in Liver Transplant Patients - Mayo Clinic

    ALT and either alkaline phosphatase or GGT remain within normal limits or ≤ 1.5 x baseline after darTregs infusion; For subjects with elevated liver tests ...

  8. Study of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP Loss - Mayo Clinic

    If ALP is > 2.5 × ULN and the increase in ALP cannot be attributed to bone metastases or other bone disease then the subject must have ALT and AST values ...

  9. Brain tumor - Doctors and departments - Mayo Clinic

    The Mayo Clinic Comprehensive Cancer Center receives funding from the National Cancer Institute and is designated as a comprehensive cancer center. This ...

  10. Arteriosclerosis / atherosclerosis - Doctors and departments - Mayo Clinic

    Mayo Clinic cardiologists, cardiovascular surgeons and others perform clinical research to develop new treatments and approaches to reduce the risk of heart ...